1Friberg M, Jennings R, Alsarraj M. Indoleamine 2,3-dioxygenase contributes to tumor cell evasion of T cell-mediated rejection[J]. Int J Cancer,2002, 101(2):151～155.
2Von Bubnoff, Dagmar MD, Daniel MD,et al. Indoleamine 2,3-dioxygenase-expressing antigen- presenting cells and peripheral T-cell tolerance: Another piece to the atopic puzzle[J]. J Allergy & Clin Immunol, 2003,112(5):854～860.
3Munn David H, Sharma Madhav D, Lee Jeffrey R,et al. Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase[J]. Science,2002, 297(5588):1867～1870.
4Lee Jeffrey R, Dalton Rory R, Messina Jane L, et al. Pattern of recruitment of immunoregulatory antigen-presenting cells in malignant melanoma[J]. Lab Investigation,2003, 83(10):1457～1466.
5Uyttenhove C, Pilotte L, Theate I, et al. Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase[J]. Nat Med, 2003,9(10):1269～1274.
6Logan GJ, Smyth CM, Earl JW, et al. HeLa cells cocultured with peripheral blood lymphocytes acquire an immuno-inhibitory phenotype through up-regulation of indoleamine 2,3-dioxygenase activity[J]. Immunology,2002, 105(4):478～487.
7Munn David H, Shafizadeh Ebrahim, Attwood John T,et al. Inhibition of t cell proliferation by macrophage tryptophan catabolism[J]. J Exp Med,1999,189(9):1363～1372.
8Li Yunyuan, Tredget Edward E, Kilani Ruhangiz T, et al. Expression of indoleamine 2,3-dioxygenase in dermal fibroblasts functions as a local immunosuppressive factor[J]. J Invest Dermatol,2004,122(4):953～964.
9Fallarino Francesca, Vacca Carmine, Orabona Ciriana, et al. Functional expression of indoleamine 2,3-dioxygenase by murine CD8[alpha]+ dendritic cells[J]. Inter immunol,2002, 14(1):65～68.
10Ursula Grohmann, Francesca Fallarino, Paolo Puccetti. Tolerance, DCs and tryptophan: much about IDO[J]. Trends in Immunol,2003,24:242～248.
